Summary

Mechanical Ventilator Market Growth & Trends

The global mechanical ventilator market size is expected to reach USD 4.2 billion by 2030, according to a new report by Grand View Research Inc. It is expected to expand at a CAGR of 4.9% from 2024 to 2030. The unprecedented dawn of COVID19, increasing incidence of chronic obstructive pulmonary disease (COPD), rising incidence of respiratory emergencies, and technological innovation in respiratory care devices are the major factors driving the market for mechanical ventilators.

Technical advancements such as rapid innovation in the field of Positive Airway Pressure (PAP) devices, portability, and improvement in battery life of transport and portable devices are the primary factors that encourage the usage of mechanical ventilators. In April 2020, InnAccel Technologies announced the introduction of a non-invasive ventilation system intended for usage in ICU with COVID-19 patients. This system was engineered and manufactured in India to treat patients with deteriorating hypoxemia. Besides, this system functions across numerous settings and clinical applications, without the necessity of continuous electricity, or a trained breathing therapist.

The WHO estimates that at present, approximately 90% of COPD deaths occur in low- and middle-income countries. Therefore, the rise in the prevalence of such diseases, new product launches, and the availability of portable, cost-contained, and easy-to-use mechanical ventilators for the treatment of respiratory conditions are expected to fuel the market growth worldwide. For instance, in August 2020, Spicejet introduced Spiceoxy, a portable, non-invasive ventilation device. The increasing awareness amongst the end users is projected to boost the demand over the forecast period.

Asia Pacific and Latin America are expected to witness lucrative growth over the forecast period. This growth is due to the presence of untapped opportunities, rising expenditure levels, and the introduction of favorable government initiatives. Market participants are constantly engaged in the development of new products in an attempt to improve presence and ensure sustainability. For instance, in April 2021, Drägerwerk AG & Co. KGaA has acquired the majority share of STIMIT AG. With this purchase, the company further increases its proficiency in the lung-protective ventilation field.

Mechanical Ventilator Market Report Highlights

• By product, critical care ventilators dominated the market with a share of over 38.0% in 2023 owing to the high adoption and installation rate in hospitals. Besides, increasing incidence of COPD, asthma, and other respiratory emergencies is a key driver of this segment

• Transport and portable ventilators are expected to register a lucrative CAGR over the forecast period. Hospitals are promoting the use of portable breathing machines to provide faster and continuous care to patients even prior to their arrival on the premises. Portable breathing machines fulfill the need of patients to obtain home care, thereby increasing their popularity

• The non-invasive ventilation mode segment held the largest revenue share in 2023 and is expected to witness the fastest growth during the forecast period. Non-invasive ventilation effectively supports and prevents the necessity for intubation in patients, thus supporting the segment growth

• The home healthcare end-use segment is expected to register a lucrative CAGR over the forecast period. This is a cost-efficient alternative to expensive hospital stays, hence is anticipated to gain popularity in the coming years

• North America dominated the market in 2023 owing to the rising geriatric population in the U.S., which is leading to a corresponding rise in the incidences of respiratory disorders along with a manufacturing boost

ページTOPに戻る

Table of Contents

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Product Type
1.2.2. End Use
1.2.3. Regional scope
1.2.4. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.4.5.1. Data for primary interviews in North America
1.4.5.2. Data for primary interviews in Europe
1.4.5.3. Data for primary interviews in Asia Pacific
1.4.5.4. Data for primary interviews in Latin America
1.4.5.5. Data for Primary interviews in MEA
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product Type outlook
2.2.2. Ventilator Mode Outlook
2.2.3. End Use Outlook
2.2.4. Regional outlook
2.3. Competitive Insights
Chapter 3. Mechanical Ventilator Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Increasing In Prevalence Of Respiratory Diseases
3.2.1.2. Technological advancement
3.2.1.3. Increasing Number Of Government Initiatives
3.2.2. Market Restraint Analysis
3.2.2.1. Capital Intensive Nature
3.2.2.2. Product Recall And Failure
3.3. Mechanical Ventilator Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Bargaining power of the suppliers
3.3.1.2. Bargaining power of the buyers
3.3.1.3. Threats of substitution
3.3.1.4. Threats from new entrants
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Economic and Social landscape
3.3.2.3. Technological landscape
3.4. Impact of COVID 19 on mechanical ventilator market
3.5. Pricing Analysis, at Regional Level
3.5.1. North America
3.5.2. Europe
3.5.3. Asia Pacific
3.5.4. Latin America
3.5.5. MEA
3.6. Unmet Need in the Market, at Regional Level
3.6.1. North America
3.6.2. Europe
3.6.3. Asia Pacific
3.6.4. Latin America
3.6.5. MEA
Chapter 4. Mechanical Ventilator Market: Product Type Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Mechanical Ventilator Market: Product Type Movement Analysis, USD Million, 2023 & 2030
4.2.1. Critical Care Ventilators
4.2.1.1. Critical Care Ventilators Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
4.2.1.2. Ventilators
4.2.1.2.1. Ventilators Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
4.2.1.3. Accessories
4.2.1.3.1. Accessories Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
4.2.2. Neonatal
4.2.2.1. Neonatal Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
4.2.2.2. Ventilators
4.2.2.2.1. Ventilators Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
4.2.2.3. Accessories
4.2.2.3.1. Accessories Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
4.2.3. Transport And Portable Ventilators
4.2.3.1. Transport And Portable Ventilators Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
4.2.3.2. Ventilators
4.2.3.2.1. Ventilators Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
4.2.3.3. Accessories
4.2.3.3.1. Accessories Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
4.2.4. Other Ventilators
4.2.4.1. Other Ventilators Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
Chapter 5. Mechanical Ventilators Market: Ventilation Mode Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Mechanical Ventilator Market: Ventilation Mode Movement Analysis, USD Million, 2023 & 2030
5.2.1. Invasive
5.2.1.1. Invasive Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
5.2.2. Non-Invasive
5.2.2.1. Non-Invasive Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
5.2.2.2. Non-Invasive Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
5.2.2.3. Continuous Positive Airway Pressure (CPAP)
5.2.2.3.1. CPAP Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
5.2.2.4. Bilevel Positive Airway Pressure (BPAP)
5.2.2.4.1. BPAP Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
5.2.2.5. Others
5.2.2.5.1. Others Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
Chapter 6. Mechanical Ventilator Market: End Use Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Mechanical Ventilator Market: End Use Movement Analysis, USD Million, 2023 & 2030
6.2.1. Hospitals
6.2.1.1. Hospitals Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
6.2.2. Home Healthcare
6.2.2.1. Home Healthcare Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
6.2.3. Others
6.2.3.1. Others Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
Chapter 7. Mechanical Ventilator Market: Regional Estimates & Trend Analysis
7.1. Regional Market Share Analysis, 2023 & 2030
7.2. Regional Market Dashboard
7.3. Global Regional Market Snapshot
7.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
7.5. North America
7.5.1. U.S.
7.5.1.1. Key country dynamics
7.5.1.2. Regulatory framework/ reimbursement structure
7.5.1.3. Competitive scenario
7.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
7.5.2. Canada
7.5.2.1. Key country dynamics
7.5.2.2. Regulatory framework/ reimbursement structure
7.5.2.3. Competitive scenario
7.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
7.6. Europe
7.6.1. UK
7.6.1.1. Key country dynamics
7.6.1.2. Regulatory framework/ reimbursement structure
7.6.1.3. Competitive scenario
7.6.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
7.6.2. Germany
7.6.2.1. Key country dynamics
7.6.2.2. Regulatory framework/ reimbursement structure
7.6.2.3. Competitive scenario
7.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
7.6.3. France
7.6.3.1. Key country dynamics
7.6.3.2. Regulatory framework/ reimbursement structure
7.6.3.3. Competitive scenario
7.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
7.6.4. Italy
7.6.4.1. Key country dynamics
7.6.4.2. Regulatory framework/ reimbursement structure
7.6.4.3. Competitive scenario
7.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
7.6.5. Spain
7.6.5.1. Key country dynamics
7.6.5.2. Regulatory framework/ reimbursement structure
7.6.5.3. Competitive scenario
7.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
7.6.6. Norway
7.6.6.1. Key country dynamics
7.6.6.2. Regulatory framework/ reimbursement structure
7.6.6.3. Competitive scenario
7.6.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
7.6.7. Sweden
7.6.7.1. Key country dynamics
7.6.7.2. Regulatory framework/ reimbursement structure
7.6.7.3. Competitive scenario
7.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
7.6.8. Denmark
7.6.8.1. Key country dynamics
7.6.8.2. Regulatory framework/ reimbursement structure
7.6.8.3. Competitive scenario
7.6.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
7.7. Asia Pacific
7.7.1. Japan
7.7.1.1. Key country dynamics
7.7.1.2. Regulatory framework/ reimbursement structure
7.7.1.3. Competitive scenario
7.7.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
7.7.2. China
7.7.2.1. Key country dynamics
7.7.2.2. Regulatory framework/ reimbursement structure
7.7.2.3. Competitive scenario
7.7.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
7.7.3. India
7.7.3.1. Key country dynamics
7.7.3.2. Regulatory framework/ reimbursement structure
7.7.3.3. Competitive scenario
7.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
7.7.4. Australia
7.7.4.1. Key country dynamics
7.7.4.2. Regulatory framework/ reimbursement structure
7.7.4.3. Competitive scenario
7.7.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
7.7.5. South Korea
7.7.5.1. Key country dynamics
7.7.5.2. Regulatory framework/ reimbursement structure
7.7.5.3. Competitive scenario
7.7.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
7.7.6. Thailand
7.7.6.1. Key country dynamics
7.7.6.2. Regulatory framework/ reimbursement structure
7.7.6.3. Competitive scenario
7.7.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
7.8. Latin America
7.8.1. Brazil
7.8.1.1. Key country dynamics
7.8.1.2. Regulatory framework/ reimbursement structure
7.8.1.3. Competitive scenario
7.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
7.8.2. Mexico
7.8.2.1. Key country dynamics
7.8.2.2. Regulatory framework/ reimbursement structure
7.8.2.3. Competitive scenario
7.8.2.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
7.8.3. Argentina
7.8.3.1. Key country dynamics
7.8.3.2. Regulatory framework/ reimbursement structure
7.8.3.3. Competitive scenario
7.8.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
7.9. MEA
7.9.1. South Africa
7.9.1.1. Key country dynamics
7.9.1.2. Regulatory framework/ reimbursement structure
7.9.1.3. Competitive scenario
7.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
7.9.2. Saudi Arabia
7.9.2.1. Key country dynamics
7.9.2.2. Regulatory framework/ reimbursement structure
7.9.2.3. Competitive scenario
7.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
7.9.3. UAE
7.9.3.1. Key country dynamics
7.9.3.2. Regulatory framework/ reimbursement structure
7.9.3.3. Competitive scenario
7.9.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
7.9.4. Kuwait
7.9.4.1. Key country dynamics
7.9.4.2. Regulatory framework/ reimbursement structure
7.9.4.3. Competitive scenario
7.9.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Company/Competition Categorization
8.3. Vendor Landscape
8.3.1. Key company market share analysis, 2023
8.3.2. Medtronic
8.3.2.1. Company overview
8.3.2.2. Financial performance
8.3.2.3. Product benchmarking
8.3.2.4. Strategic initiatives
8.3.3. Abbott
8.3.3.1. Company overview
8.3.3.2. Financial performance
8.3.3.3. Product benchmarking
8.3.3.4. Strategic initiatives
8.3.4. Boston Scientific Corporation
8.3.4.1. Company overview
8.3.4.2. Financial performance
8.3.4.3. Product benchmarking
8.3.4.4. Strategic initiatives
8.3.5. BIOTRONIK
8.3.5.1. Company overview
8.3.5.2. Financial performance
8.3.5.3. Product benchmarking
8.3.5.4. Strategic initiatives
8.3.6. MicroPort Scientific Corporation
8.3.6.1. Company overview
8.3.6.2. Financial performance
8.3.6.3. Product benchmarking
8.3.6.4. Strategic initiatives
8.3.7. Koninklijke Philips N.V.
8.3.7.1. Company overview
8.3.7.2. Financial performance
8.3.7.3. Product benchmarking
8.3.7.4. Strategic initiatives
8.3.8. Stryker
8.3.8.1. Company overview
8.3.8.2. Financial performance
8.3.8.3. Product benchmarking
8.3.8.4. Strategic initiatives
8.3.9. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
8.3.9.1. Company overview
8.3.9.2. Financial performance
8.3.9.3. Product benchmarking
8.3.9.4. Strategic initiatives
8.3.10. NIHON KOHDEN CORPORATION
8.3.10.1. Company overview
8.3.10.2. Financial performance
8.3.10.3. Product benchmarking
8.3.10.4. Strategic initiatives
8.3.11. Schiller AG
8.3.11.1. Company overview
8.3.11.2. Financial performance
8.3.11.3. Product benchmarking
8.3.11.4. Strategic initiatives
8.3.12. ResMed
8.3.12.1. Company overview
8.3.12.2. Financial performance
8.3.12.3. Product benchmarking
8.3.12.4. Strategic initiatives
8.3.13. Fisher & Paykel Healthcare Limited
8.3.13.1. Company overview
8.3.13.2. Financial performance
8.3.13.3. Product benchmarking
8.3.13.4. Strategic initiatives
8.3.14. Drägerwerk AG & Co. KGaA
8.3.14.1. Company overview
8.3.14.2. Financial performance
8.3.14.3. Product benchmarking
8.3.14.4. Strategic initiatives
8.3.15. Getinge AB
8.3.15.1. Company overview
8.3.15.2. Financial performance
8.3.15.3. Product benchmarking
8.3.15.4. Strategic initiatives
8.3.16. ZOLL Medical Corporation (Asahi Kasei Corporation)
8.3.16.1. Company overview
8.3.16.2. Financial performance
8.3.16.3. Product benchmarking
8.3.16.4. Strategic initiatives
8.3.17. Air Liquide
8.3.17.1. Company overview
8.3.17.2. Financial performance
8.3.17.3. Product benchmarking
8.3.17.4. Strategic initiatives
8.3.18. VYAIRE MEDICAL, INC.
8.3.18.1. Company overview
8.3.18.2. Financial performance
8.3.18.3. Product benchmarking
8.3.18.4. Strategic initiatives
8.3.19. GE Healthcare
8.3.19.1. Company overview
8.3.19.2. Financial performance
8.3.19.3. Product benchmarking
8.3.19.4. Strategic initiatives
8.3.20. Hamilton Medical
8.3.20.1. Company overview
8.3.20.2. Financial performance
8.3.20.3. Product benchmarking
8.3.20.4. Strategic initiatives
8.3.21. Smiths Group plc
8.3.21.1. Company overview
8.3.21.2. Financial performance
8.3.21.3. Product benchmarking
8.3.21.4. Strategic initiatives
8.3.22. Allied Medical LLC (A Flexicare Company)
8.3.22.1. Company overview
8.3.22.2. Financial performance
8.3.22.3. Product benchmarking
8.3.22.4. Strategic initiatives
8.3.23. aXcent Medical GmbH
8.3.23.1. Company overview
8.3.23.2. Financial performance
8.3.23.3. Product benchmarking
8.3.23.4. Strategic initiatives
8.3.24. Metran Co., Ltd
8.3.24.1. Company overview
8.3.24.2. Financial performance
8.3.24.3. Product benchmarking
8.3.24.4. Strategic initiatives
8.3.25. MAGNAMED
8.3.25.1. Company overview
8.3.25.2. Financial performance
8.3.25.3. Product benchmarking
8.3.25.4. Strategic initiatives
8.3.26. Avasarala Technologies Limited
8.3.26.1. Company overview
8.3.26.2. Financial performance
8.3.26.3. Product benchmarking
8.3.26.4. Strategic initiatives
8.3.27. Airon Corporation
8.3.27.1. Company overview
8.3.27.2. Financial performance
8.3.27.3. Product benchmarking
8.3.27.4. Strategic initiatives
8.3.28. Bio-Med Devices
8.3.28.1. Company overview
8.3.28.2. Financial performance
8.3.28.3. Product benchmarking
8.3.28.4. Strategic initiatives
8.3.29. Hill-Rom (Baxter)
8.3.29.1. Company overview
8.3.29.2. Financial performance
8.3.29.3. Product benchmarking
8.3.29.4. Strategic initiatives
8.3.30. HEYER Medical AG
8.3.30.1. Company overview
8.3.30.2. Financial performance
8.3.30.3. Product benchmarking
8.3.30.4. Strategic initiatives
8.3.31. Leistung Engineering Pvt. Ltd.
8.3.31.1. Company overview
8.3.31.2. Financial performance
8.3.31.3. Product benchmarking
8.3.31.4. Strategic initiatives